THE WOODLANDS, Texas , Oct. 29, 2025 /PRNewswire/ -- Target Hospitality Corp. ("Target Hospitality", "Target" or the "Company") (NASDAQ: TH), one of North America's largest providers of vertically integrated modular accommodations and value-added hospitality services, today announced that it will release its third quarter 2025 financial results before the market opens on Thursday, November 6, 2025. The Company has also scheduled a conference call for Thursday, November 6, 2025, at 9:00 am Eastern Time (8:00 am Central Time) to discuss the results.

AUSTIN, Minn. , Oct. 29, 2025 /PRNewswire/ -- Leadership Appointment Hormel Foods Corporation (NYSE: HRL) today announced the appointment of Paul Kuehneman as interim chief financial officer and controller, effective October 27, 2025.

MONTREAL, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Gildan Activewear Inc. (GIL: TSX and NYSE) today announced results for the third quarter ended September 28, 2025 and updated its full year 2025 guidance.

DALLAS , Oct. 29, 2025 /PRNewswire/ -- Brinker International, Inc. (NYSE: EAT) today announced its financial results for the first quarter ended September 24, 2025. First Quarter Fiscal 2026 Financial Highlights "Chili's continues to deliver industry leading results with first quarter sales of +21% and traffic of +13%, against a tough macro environment," said Kevin Hochman, President & CEO of Brinker International.

HERNDON, Va., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Navient (Nasdaq: NAVI) today posted its 2025 third quarter financial results.

RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Commission (EC) has approved KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, as monotherapy for the treatment of resectable locally advanced head and neck squamous cell carcinoma (LA-HNSCC) as neoadjuvant treatment, continued as adjuvant treatment in combination with radiation therapy with or without concomitant cisplatin and then as monotherapy in adul.

SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.2075 per share on its common stock. The quarterly dividend is payable on November 26, 2025, to shareholders of record as of the close of business on November 12, 2025. About Kenvue Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, John.

NEW YORK--(BUSINESS WIRE)--Evercore Inc. (NYSE: EVR): Third Quarter Results Year to Date Results U.S. GAAP Adjusted U.S. GAAP Adjusted Q3 2025 Q3 2024 Q3 2025 Q3 2024 YTD 2025 YTD 2024 YTD 2025 YTD 2024 Net Revenues ($ mm) $ 1,038.9 $ 734.2 $ 1,047.1 $ 739.5 $ 2,567.5 $ 2,004.3 $ 2,585.8 $ 2,022.1 Operating Income ($ mm) $ 216.2 $ 122.0 $ 227.9 $ 134.6 $ 477.8 $ 314.4 $ 501.2 $ 339.5 Net Income Attributable to Evercore Inc. ($ mm).

Valero Energy on Wednesday named Homer Bhullar as CFO effective January 1, 2026.

Canadian Natural provides an AI-resistant hedge with stable, non-discretionary energy demand, offering protection from tech disruption while benefiting from potential AI-driven energy consumption growth. Its long-life, low-decline oil sands assets and low breakeven ($40s WTI) ensure resilient margins and strong cash generation across commodity cycles. With 5%+ yield, 22% dividend CAGR, and a pending 100% FCF payout post $12B net debt, CNQ offers both income stability and upside.

CVS Health raised its guidance for the rest of the year, boosted by improved performance at its Aetna insurance unit.

CVS Health Wednesday reported a $4 billion third-quarter loss related to the reduced value of its Oak Street Health primary care facilities, but the company is getting a handle on health costs that have hit its Aetna health insurance business.

This isn't the time for investors to buy the dip, with geopolitical risks fading and bullion still up 53% for the year.

Carrier Global shares have underperformed in 2025, driven by a sharp decline in North American residential HVAC sales. Carrier cut its 2025 guidance 13% to $2.65, but the share price stability on earnings day suggests the market has priced this in. Despite residential weakness, CARR benefits from strong commercial HVAC, data center cooling, growth in Asia/the Middle East, and transportation refrigeration.

SAN ANTONIO--(BUSINESS WIRE)--Valero Energy Corporation (NYSE: VLO, “Valero”) announced today that Homer Bhullar, who has served as Valero's Vice President-Investor Relations and Finance since April 29, 2021, has been appointed by Valero's Board of Directors to serve as Senior Vice President and Chief Financial Officer, effective January 1, 2026. Mr. Bhullar will succeed Jason Fraser, who will remain as Executive Vice President and Chief Financial Officer until his retirement from the position.

CVS Health raised its annual adjusted profit forecast on Wednesday, aided by improved pharmacy revenues, but also announced a $5.73 billion writedown of healthcare businesses including its in-pharmacy MinuteClinics.

Applied Digital (APLD 0.13%) is transforming into one of America's fastest-scaling artificial intelligence (AI) infrastructure developers, with $16 billion in long-term deals powering its growth. From data centers to hyperscaler partnerships, its bold expansion signals a massive shift in AI computing -- and a potentially lucrative future for investors.

Verizon beat Wall Street estimates for quarterly profit and wireless subscriber additions on Wednesday, as promotions around the recent iPhone launches helped the U.S. wireless service provider attract more customers.

Nvidia is set to be the first company ever to be valued at $5 trillion. A new revenue forecast has Wall Street recalibrating expectations.

CVS Health reported third-quarter earnings and revenue that blew past estimates and raised its adjusted profit outlook, as the company sees improvement in its insurance unit. The quarterly results cap David Joyner's first full year as CEO of the company, which struggled to drive higher profits and improve its stock performance under Karen Lynch.